Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan
July 31, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
In Network Access for More Than 6 Million Members PARSIPPANY, NJ, July 31, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has contracted with Blue...
Interpace Announces Contract with Blue Shield of California for ThyGeNEXT® & ThyraMIR®
July 29, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Four Million Members Gain in-Network Access PARSIPPANY, NJ, July 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has entered in to a contract...
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
July 15, 2019 16:10 ET
|
Interpace Diagnostics Group, Inc.
Conference Call to be Held Tomorrow, Tuesday July 16, 2019 @ 8:30 am ET PARSIPPANY NJ, July 15, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the...
Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross
June 20, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY NJ, June 20, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that its ThyGeNEXT™ and ThyraMIR® tests for thyroid cancer are now covered by...
Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
April 02, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®
December 17, 2018 06:50 ET
|
Interpace Diagnostics Group, Inc.
BarreGEN® is Interpace’s Lead Molecular Diagnostic Pipeline Product for Barrett’s Esophagus Parsippany, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace”)...
Interpace Diagnostics to Present at the 36th Annual Lab Institute 2018
October 22, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
Discussing Methods for Securing Coverage and Reimbursement for New Technologies PARSIPPANY, NJ, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today...
Interpace Diagnostics CEO Provides Corporate Update
October 10, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) is pleased to provide a corporate update to shareholders on current business activities from its Chief...